Establishment of snake venom gland organoids from a novel family, Colubridae

This study pioneers the establishment of venom gland organoids from the abundant Colubridae family of non-front-fanged snakes, successfully demonstrating their ability to produce toxins in vitro to overcome the limitations of traditional venom extraction.

The Gist

Imagine a snake's venom gland not just as a biological factory, but as a high-tech 3D printer that can be taken out of the snake and kept running in a lab. That is essentially what this paper is about.

Here is the story of the research, broken down into simple concepts and everyday analogies:

1. The Problem: The "Hard-to-Reach" Snakes

For a long time, scientists have been obsessed with studying the venom of "front-fanged" snakes (like cobras and vipers). These snakes are like heavy-duty delivery trucks: they have big, hollow fangs and a pressurized tank that shoots venom out with force. Because they are dangerous and medically important, we have built many "models" (like 3D cell cultures) to study them in the lab without hurting the snakes.

However, there is a huge group of snakes called Colubridae (rear-fanged snakes, like the Mangrove Catsnake). They are like bicycle couriers: they don't have big fangs or a pressurized tank. Instead, they have small, grooved teeth at the back of their mouths and a gland that slowly oozes venom while they chew.

• The Challenge: These snakes are everywhere (70% of all snakes!), but their venom is hard to get. You can't just "milk" them easily; you often have to squeeze them or use chemicals that ruin the venom sample. Plus, they produce very little venom, making it hard to study.

2. The Solution: The "Mini-Snake-Gland" in a Dish

The researchers decided to build a miniature, self-replicating version of the snake's venom gland in a petri dish. They call these organoids.

Think of an organoid like a clay sculpture that, once you give it the right water and nutrients, starts to grow, shape itself, and even start "printing" its own products.

• They took tiny pieces of the Mangrove Catsnake's gland.
• They put them in a special gel (like a nutrient-rich Jell-O).
• They added a "growth cocktail" (a mix of vitamins and signals) to tell the cells: "Hey, you are a venom gland! Start building yourself!"

3. The Big Breakthrough

For the first time, they successfully grew these "mini-glands" from a rear-fanged snake.

• The Result: The little blobs of cells grew into tiny, 3D structures that looked just like the real thing under a microscope. They had the same shape and even had the same "mucus-secreting" cells as the real snake.
• The Catch: These rear-fanged glands were a bit more stubborn than the front-fanged ones. They grew slower and were harder to keep alive, like trying to keep a rare, delicate houseplant alive compared to a hardy cactus.

4. Do They Actually Make Venom?

The million-dollar question: Do these mini-glands actually make poison?

• Yes! When the researchers broke open the organoids, they found the same toxic proteins found in the real snake's venom.
• They tested the "poison" and found it could:
  • Break down muscle tissue (a common venom effect).
  • Disrupt nerve signals (which is how many snake bites cause paralysis).
• The Analogy: It's like building a tiny, fake bakery in a lab. You check the ovens, and sure enough, the little bakery is actually baking real bread, not just dough.

5. Why Does This Matter?

This is a game-changer for two main reasons:

1. Ethics and Safety: Instead of catching wild snakes, squeezing them, and potentially killing them to get a drop of venom, scientists can now just grow more "mini-glands" in a dish. It's like having an infinite supply of venom without ever harming a single animal.
2. Unlocking the Unknown: Since 70% of snakes are rear-fanged and we know very little about their venom, this "mini-gland" technology is a key to a locked door. It allows scientists to study how these snakes evolved, what their venom does, and how to make better antivenoms for them.

The Bottom Line

The scientists have successfully created a living, breathing "venom factory" in a jar for a type of snake that was previously too difficult to study. This opens the door to understanding the vast, mysterious world of snake venom without needing to catch and harm the snakes themselves. It's a small step for a petri dish, but a giant leap for snake science.

Technical Summary

1. Problem Statement

• Knowledge Gap: While front-fanged snakes (Elapidae, Viperidae) are well-studied due to their medical importance, non-front-fanged snakes (Colubridae and others) comprise ~70% of extant snake species. Their venom systems (Duvernoy's glands) and toxin compositions remain poorly understood.
• Technical Limitations: Research on rear-fanged snakes is hindered by:
  • Low Venom Yields: Difficult to extract sufficient venom for study.
  • Welfare Challenges: Extraction often requires chemical stimulation (e.g., pilocarpine) or invasive procedures.
  • Lack of Models: No established in vitro cellular models existed for rear-fanged snakes, unlike the recently developed organoids for front-fanged species.
• Goal: To establish a renewable, in vitro model (organoids) for a non-front-fanged snake to study venom production, evolution, and toxin function without the limitations of traditional extraction.

2. Methodology

• Species Selection:
  • Primary Subject: Boiga dendrophila (Mangrove Catsnake), a rear-fanged Colubridae species.
  • Comparators: Bitis arietans (Viperidae, front-fanged) and Naja haje (Elapidae, front-fanged) organoids were used as controls.
• Organoid Establishment:
  • Tissue Source: Venom glands were dissected from euthanized snakes (fresh) or from tissue stored in liquid nitrogen (90% FBS/10% DMSO).
  • Digestion: Tissue was treated with an antibiotic cocktail and digested with collagenase (1 mg/ml) at 32°C for up to 1 hour.
  • Culture Conditions: Digested structures were embedded in Cultrex Basement Membrane Extract (BME) and cultured in "Expansion Media" containing growth factors (EGF, FGF10, Noggin, R-spondin, etc.) and ROCK inhibitor (Y-27632).
  • Differentiation: Organoids were switched to "Differentiation Media" (lacking specific growth factors like Noggin/R-spondin) for 7 days to induce toxin production.
• Analytical Techniques:
  • Histology: H&E and Periodic Acid-Schiff (PAS) staining to assess morphology and mucosecretory cells.
  • Western Blotting: Used EchiTAb-Plus-ICP (for B. arietans) and Neuro Polyvalent Snake Antivenom (NPAV, for B. dendrophila) to detect toxin proteins.
  • Activity Assays:
    • SVMP: Quenched fluorogenic substrate assay.
    • PLA2: Secretory phospholipase A2 assay kit.
    • Neurotoxicity: Inhibition of muscle-type nicotinic acetylcholine receptor (nAChR) on TE671 cells using a membrane potential dye.

3. Key Contributions

• First-of-its-Kind Model: This study reports the first successful establishment of venom gland organoids from a non-front-fanged snake (Boiga dendrophila, Colubridae family).
• Comparative Analysis: It provides a direct comparison between rear-fanged (Duvernoy's gland) and front-fanged venom gland organoids, highlighting differences in expansion rates and morphology.
• Toxin Production Validation: Demonstrates that rear-fanged organoids can synthesize functional venom toxins in vitro, including metalloproteinases, phospholipases, and neurotoxins.
• Methodological Insight: Identifies challenges specific to Colubridae organoids, such as the inability to culture from cryopreserved tissue and the difficulty in long-term expansion compared to Elapidae.

4. Key Results

• Organoid Morphology & Expansion:
  • B. dendrophila organoids formed lobular structures with thick cellular swirls and small lumens, distinct from the larger structures of B. arietans.
  • Expansion Challenge: B. dendrophila and B. arietans organoids were difficult to expand long-term compared to N. haje (Elapidae), which expanded rapidly.
  • Cryopreservation Failure: Attempts to establish B. dendrophila organoids from frozen tissue were unsuccessful, unlike the success with fresh tissue.
• Histology:
  • Organoids closely mimicked native tissue, showing PAS-positive granules indicative of mucosecretory cells.
  • Differentiation of B. arietans organoids induced cell death (caspase-3 positive) and degradation of the extracellular matrix, likely due to high SVMP activity breaking down the BME.
• Toxin Composition (Western Blot):
  • Undifferentiated Organoids: Produced SVMPs (55 kDa) and PLA2s (10-15 kDa) in B. arietans. In B. dendrophila, bands corresponding to CRISPs (20 kDa) and SVMPs (55 kDa) were detected.
  • Differentiated Organoids: Showed reduced toxin profiles. B. arietans lost SVMP/PLA2 bands; B. dendrophila retained some high molecular weight bands (55-100 kDa) but lost low molecular weight bands.
  • Note: 3FTxs (6-8 kDa) in B. dendrophila were not clearly detected, likely due to low cross-reactivity of the available antivenom (NPAV).
• Functional Activity:
  • SVMP & PLA2: Undifferentiated organoid lysates showed significant enzymatic activity for both SVMP and PLA2, comparable to native venom. Differentiated lysates showed a loss of this activity.
  • Neurotoxicity: B. dendrophila native venom inhibited nAChR with an IC50 of 0.86 µg/ml. Organoid lysates showed a slight, non-significant decrease in nAChR activation, likely due to lower toxin concentrations and interference from intracellular non-toxin proteins released during sonication.

5. Significance

• Renewable Venom Source: This model offers a solution to the ethical and logistical challenges of harvesting venom from rear-fanged snakes, providing a sustainable source for toxin research.
• Evolutionary Insights: The ability to culture Duvernoy's glands allows researchers to study the evolutionary transition from rear-fanged to front-fanged venom systems and the diversification of prey-specific toxins (e.g., Boiga 3FTxs).
• Future Applications: The platform enables high-throughput screening of venom components, study of venom synthesis pathways, and the generation of toxins for antivenom development without relying on live snake milking.
• Limitations & Future Work: The study highlights the need for improved sub-culture protocols for Colubridae organoids, better methods for toxin harvesting (to reduce non-toxin protein contamination), and advanced proteomics/transcriptomics to fully characterize the toxin repertoire, particularly the elusive 3FTxs in this model.